Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,751 total articles

Fiserv Small Business Index Shows YoY Sales Growth in August as Consumers Continue to Spend More on Fewer Visits

Fiserv Small Business Index Shows YoY Sales Growth in August as Consumers Continue to Spend More on Fewer Visits

Fiserv's Small Business Index for August 2026 shows a 1.3% year-over-year growth in small business sales despite a decline in foot traffic for the tenth consecutive month. Consumers are spending more per visit but making fewer trips. Key sectors like restaurants see mixed results: full-service restaurants report slight sales growth while limited-se…

Greenland Mines Shareholder Letter Recaps Six Months of Achievement; Highlights Coming Milestones for Q4 2026

Greenland Mines Shareholder Letter Recaps Six Months of Achievement; Highlights Coming Milestones for Q4 2026

Greenland Mines Ltd (Nasdaq: GRML) recaps six months of rapid progress following its rebrand and Nasdaq listing. Key achievements include the acquisition of the high-grade Sarfartoq neodymium-praseodymium rare earth project, an upgraded mineral resource estimate for the Skaergaard palladium-gold-platinum project, strategic investments and offtake a…

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Kala Bio and Virotek have entered an exclusive U.S. distribution and reseller agreement for Virotek's ophthalmology genetic testing program. Kala will handle marketing and sales, targeting a specialized ophthalmic genetic market while laying groundwork for future expansion into oncology, preventive health, and telehealth verticals. The partnership …

Cycurion Announces Approximately $800,000 in Annual Contract Spend, Accelerating Commercial Expansion

Cycurion Announces Approximately $800,000 in Annual Contract Spend, Accelerating Commercial Expansion

Cycurion, Inc. announced new contracts totaling approximately $800,000 in annual spend, marking a strategic expansion into the commercial healthcare and life sciences sectors. These contracts include support for a pharmaceutical AI Center of Excellence, new engagement with NACCHO, and additional public health work, emphasizing the company's growth …

ZenaTech’s ZenaDrone Advances Precision Agriculture Solutions with Initial Prototype and Start of Testing of IQ Octo Designed for Autonomous Drone-Based Spraying and Seeding

ZenaTech’s ZenaDrone Advances Precision Agriculture Solutions with Initial Prototype and Start of Testing of IQ Octo Designed for Autonomous Drone-Based Spraying and Seeding

ZenaTech's subsidiary ZenaDrone has completed the initial prototype of its IQ Octo autonomous drone, designed for precision spraying and seeding in agriculture. The drone aims to improve farming efficiency by reducing input costs and enabling precise application of fertilizers and seeds through autonomous operations. Field testing is set to begin s…

La Rosa Holdings Announces 1-for-6 Reverse Stock Split

La Rosa Holdings Announces 1-for-6 Reverse Stock Split

La Rosa Holdings Corp., a Nasdaq-listed real estate and PropTech company, announced a 1-for-6 reverse stock split effective September 8, 2026, aimed at maintaining compliance with Nasdaq's minimum bid price requirements. The reverse split consolidates shares to reduce outstanding share count and applies to options, warrants, and convertible securit…

Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

Onconetix, a biotech company listed on Nasdaq, announced a pilot program by its pending acquisition target, Realbotix LLC, to deploy AI-powered humanoid robots as presenters, hosts, and brand ambassadors at live events for a major European telecommunications company. The pilot aims to explore robotic applications beyond one-on-one interactions into…

SEALSQ Announces wolfTPM Support for Its Post-Quantum TPM Technology

SEALSQ Announces wolfTPM Support for Its Post-Quantum TPM Technology

SEALSQ Corp announced that wolfSSL's wolfTPM now supports SEALSQ's QVault TPM, marking a market-first implementation of post-quantum cryptographic algorithms in TPM 2.0 hardware. This integration ensures perfect interoperability and scalability, enabling developers to utilize advanced ML-DSA and ML-KEM algorithms in embedded applications, thereby e…

Quantum X Labs Announces Key Milestone: Achieves Efficient Geometric Encoding of Complex Nuclear Environments

Quantum X Labs Announces Key Milestone: Achieves Efficient Geometric Encoding of Complex Nuclear Environments

Quantum X Labs Inc. announced a significant advancement in nuclear quantum operations by developing an efficient approach to encode complex spatial geometries within a quantum transport framework. This breakthrough allows scalable quantum algorithms to better simulate particle transport in realistic nuclear environments, which traditionally face hi…

Cipher Digital Begins Development of Lateral Pipelines to Facilitate Data Center Expansion via Bring-Your-Own-Generation

Cipher Digital Begins Development of Lateral Pipelines to Facilitate Data Center Expansion via Bring-Your-Own-Generation

Cipher Digital has begun constructing lateral pipelines to supply natural gas to its industrial-scale data center sites, enabling on-site electricity generation capable of supporting up to 2.5 gigawatts. This development will enhance the company's leasable high-performance computing data center capacity and supports their plan to contribute to grid…

SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company

SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company

SRX Global Inc. provided a positive update on its portfolio company ARMR Sciences, a clinical-stage biodefense firm developing ARMR-100, an anti-fentanyl vaccine candidate. Phase 1/2 trials report strong immune response with favorable safety data, no severe adverse events, and dose escalation showing encouraging antibody responses. ARMR also receiv…

Ocean Power Technologies Selects Palantir Foundry to Accelerate Growth in Autonomous Maritime Operations

Ocean Power Technologies Selects Palantir Foundry to Accelerate Growth in Autonomous Maritime Operations

Ocean Power Technologies (OPTT) announces the integration of Palantir Foundry, implemented by Palantir partner Foxtrot Professional Services, to enhance operational capabilities across manufacturing, supply chain, fleet operations, and customer support. This move supports OPT's strategic shift towards scalable, repeatable autonomous maritime system…

60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference

60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference

60 Degrees Pharmaceuticals, a U.S.-based biotech company focused on developing treatments for vector-borne diseases, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference scheduled for September 14-16, 2026. The company will provide an on-demand presentation starting September 11, with management available for …

General Fusion to Participate in Upcoming Investor Conferences

General Fusion to Participate in Upcoming Investor Conferences

General Fusion Group Ltd., a Nasdaq-listed company pioneering Magnetized Target Fusion technology, announced that its leadership team will attend several major investor conferences in September and October 2026. The company aims to advance its LM26 fusion demonstration machine and commercialize cost-effective, carbon-free fusion energy by the mid-2…

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics announced participation of its management team in the Cantor Global Healthcare Conference and the C. Wainwright 28th Annual Global Investment Conference in September 2026. The company provided webcast access details and highlighted its focus on developing novel small molecule medicines for neurological and neuropsychiatric disorde…